Retrieved from Nunes, E
GLP-1 RAs are increasingly prescribed to reproductive-aged female patients for type 2 diabetes and obesity, yet menstrual dysregulation was not systematically captured or reported as an adverse effect in the pivotal clinical trials for these agents, leaving a critical gap in our understanding of their gynecologic safety profile, stated researchers Connor Frey, MD, and Mahyar Etminan, PharmD, MSc, from the University of British Columbia
But if you don't eat fish regularly, a fish oil supplement is a good idea
Critically, you don't actually need to have eaten or be full for semaglutide to work
Apovian has seen patients who lose weight on GLP-1 drugs develop osteopenia, or low bone mass
"Nausea, diarrhoea and vomiting were most frequently reported during dose escalation, most were mild to moderate in severity and of short duration